Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology
Science Advances · 2023
DOI: 10.1126/sciadv.adf0567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Nicholas J Hess und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
An important paradigm in allogeneic hematopoietic cell transplantations (allo-HCTs) is the prevention of graft-versus-host disease (GVHD) while preserving the graft-versus-leukemia (GVL) activity of donor T cells. From an observational clinical study of adult allo-HCT recipients, we identified a CD4 + /CD8 + double-positive T cell (DPT) population, not present in starting grafts, whose presence was predictive of ≥ grade 2 GVHD. Using an established xenogeneic transplant model, we reveal that the DPT population develops from antigen-stimulated CD8 T cells, which become transcriptionally, metabolically, and phenotypically distinct from single-positive CD4 and CD8 T cells. Isolated DPTs were sufficient to mediate xeno-GVHD pathology when retransplanted into naïve mice but provided no survival benefit when mice were challenged with a human B-ALL cell line. Overall, this study reveals human DPTs as a T cell population directly involved with GVHD pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
- University of Wisconsin Carbone Cancer Center, Madison, WI, USA.
- Morgridge Institute for Research, Madison, WI, USA.
- Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA.
ORCID-Profile: Nicholas J Hess, David P Turicek, Jeremiah Riendeau, Sean J McIlwain, Emmanuel Contreras Guzman, Kalyan Nadiminti, Amy Hudson, Natalie S Callander, Melissa C Skala, Jenny E Gumperz, Peiman Hematti, Christian M Capitini
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Hess, N. J., Turicek, D. P., Riendeau, J., McIlwain, S. J., Contreras Guzman, E., Nadiminti, K., Hudson, A., Callander, N. S., Skala, M. C., Gumperz, J. E., Hematti, P., & Capitini, C. M. (2023). Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology. Science Advances. https://doi.org/10.1126/sciadv.adf0567
Vancouver
Hess NJ, Turicek DP, Riendeau J, McIlwain SJ, Contreras Guzman E, Nadiminti K, et al. Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology. Science Advances. 2023. doi:10.1126/sciadv.adf0567
BibTeX
@article{Hess2023,
author = {Hess, Nicholas J and Turicek, David P and Riendeau, Jeremiah and McIlwain, Sean J and Contreras Guzman, Emmanuel and Nadiminti, Kalyan and Hudson, Amy and Callander, Natalie S and Skala, Melissa C and Gumperz, Jenny E and Hematti, Peiman and Capitini, Christian M},
title = {Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adf0567}
}
EUVIMED